loader2
Login OPEN ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations

SEBI's new rule of not freezing demat and MF folios over nomination failure for existing customer

21 Jun 2024|
5 min read |
by ICICI Securities Team

You have not added nominee details to your Demat and mutual fund folio. Are you worried that your Demat account will freeze now? Though it is good to give nominee details for all your investments, if you have not for your mutual fund, your account will not freeze. As per SEBI's previous circular, the accounts without nominee details were to be frozen. However, as per SEBI's recent circular, it will not freeze the Demat account of investors in the absence of nomination details. Let us look at the new circular in detail.

SEBI's rule

As per the new rule, in the event of non-submission of 'choice of nomination', your Demat and MF folio account will not freeze. At the same time, the market regulator has extended the deadline for existing MF investors to submit their 'choice of nomination' till the end of the month - 30 June 2024. Here is how the new rule will benefit you and other investors:

  • Prevents Disruption: This change ensures existing investors can continue to access and manage their investments even if they have not submitted a nomination yet.
  • Focuses on Awareness: The emphasis seems to be shifting towards encouraging investors to nominate beneficiaries rather than penalizing them for not doing so.

Choice on Nomination

The 'choice of nomination' refers to the process by which an investor designates one or more individuals (nominees) to receive the benefits of their investment holdings in the event of the investor's death. It is a legal arrangement that ensures investors' assets are transferred smoothly and directly to the chosen nominees without undergoing the lengthy and often complicated probate process.

In case of

  • Demat accounts - depository participants
  • Mutual fund folios - AMCs and RTAs

shall encourage the demat account holders/ mutual fund unit holders to update the ‘choice of nomination’. It will be encouraged by sending a communication on a fortnightly basis (two weeks) via emails and SMS to all such unit holders who have not provided the ‘choice of nomination’. The communication should guide demat account holders/mutual fund unit holders to provide a ‘choice of nomination'.

Also, to encourage the existing investors to provide a ‘choice of nomination’, a pop-up shall be provided on the web/mobile application/platform to the investors by depositories and depository participants while logging into the demat account and by AMCs (including MF RTAs, other platforms providing online execution services).

Other Important Points

Please note that the new rule applies only to existing investors - if you are already invested. If you are a new investor opening demat accounts or MF folios, you have to complete the nomination process. While investors benefit from this rule change, companies managing demat accounts or MFs will continue to encourage nomination completion for better record-keeping and smoother inheritance processes.

To keep things simple, the latest circular said that only three fields are to be provided mandatorily for updating nomination - nominee name, percentage allocation, and relationship with the account holder.

Before you go

SEBI's new rule offers more flexibility for existing investors regarding demat and MF account nominations. However, we highly recommended to nominate a beneficiary for all your investments (FDs, property, mutual funds, etc) to ensure a hassle-free inheritance process for your loved ones.

Disclaimer: ICICI Securities Ltd.( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Centre, H. T. Parekh Marg, Churchgate, Mumbai - 400020, India, Tel No : 022 - 2288 2460, 022 - 2288 2470.  The contents herein above shall not be considered as an invitation or persuasion to trade or invest.  Investments in securities market are subject to market risks, read all the related documents carefully before investing. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. The contents are solely for informational and educational purpose.

Share
instagram facebook twitter linkedin mail whatsApp
Did you enjoy this article?

Recent Articles

View all

Repo Rate Hike Explained: Impact on Loans, Deposits, Bonds and Stock Market

13 Oct 2026

The Reserve Bank of India (RBI) held its 63rd Monetary Policy Committee (MPC) meeting from October 5 to 7, 2026. It raised the policy repo rate by 25 basis points. The stance was also changed from ‘neutral’ to ‘calibrated tightening’. India’s economy continued to show strong momentum, with real Gross Domestic Product (GDP) growing by 7.8% in Q1 FY2026-27. While inflation rose to 4.8% in August, the overall economic outlook remained positive. However, rise in crude oil prices amid renewed tensions in West Asia added to global uncertainties. This made it imperative for the RBI to strike a balance between the economic growth and price stability....

Jio Platforms IPO: DRHP highlights, Issue Details and Key Numbers

09 Oct 2026

Jio Platforms is the company behind Reliance Jio's mobile network, home broadband and a growing line-up of AI-powered products. The company has filed Draft Red Herring Prospectus (DRHP) with SEBI on June 19, 2026. This gives details about how the Jio Platforms IPO is structured, who currently owns the company, and where the raised money will be used. Jio Platforms is a platform built on proprietary digital technology and pan-India connectivity, designed to widen access to digital services across the country. The actual network runs through its subsidiary, Reliance Jio Infocomm Limited (RJIL), which served 524.4 million customers as of March 31, 2026....

Natco Pharma Ltd. Rights Issue: Price, Record Date, Entitlement Ratio And Key Details

09 Oct 2026

The Natco Pharma Ltd. rights issue is proposed at ₹750 per share, with eligible shareholders entitled to two rights equity shares for every 21 fully paid-up equity shares held on the record date. The issue is scheduled to open on October 12, 2026, and close on October 22, 2026. The pharmaceutical company plans to raise up to ₹1,279.35 crore through the issue, subject to full subscription and the finalisation of the basis of allotment....

Download
ICICI Direct app

Invest, Track, and Manage your Portfolio Anytime, Anywhere

Download
ICICI Direct app

Invest, Track, and Manage your Portfolio Anytime, Anywhere